Équipe d'Allurion
About Allurion

Meet The Team

Meet The Team

Allurion is a global company with a global vision. We have assembled the brightest minds across industries and the world to pioneer our mission to end obesity.

Leadership
Allurion CEO Shantanu Gaur
Dr. Shantanu Gaur
Chief Executive Officer and Co-Founder
Ram
Ram Chuttani
MD - Chief Medical Officer and Founding Partner
Benoit Chardon
Benoit Chardon
Chief Commercial Officer
Chris
Chris Geberth
Chief Financial Officer
Chris
Chris Robinson
Sr VP of Global Operations
joyce
Joyce Johnson
VP of Regulatory Affairs and Quality Assurance
jeff
Jeff Feldgoise
Sr VP Digital
Eryn Bailey
Eryn-Ashlei Bailey
Chief of Staff
Emily Pullen VP of People
Emily Pullen
VP of People
Board of Directors
Allurion CEO Shantanu Gaur
Dr. Shantanu Gaur

Shantanu Gaur co-founded Allurion Technologies with Samuel Levy in 2009. Shantanu completed his A.B. in Biology from Harvard College, where he graduated summa cum laude with election to Phi Beta Kappa. Shantanu received his M.D. from Harvard Medical School.

Samuel Levy
Dr. Samuel Levy

Samuel Levy co-founded Allurion Technologies with Shantanu Gaur in 2009. Samuel graduated summa cum laude with a B.S. in Molecular Biophysics and Biochemistry from Yale College and with an M.D. from Harvard Medical School. He was a Fulbright Scholar to France and served pharmaceutical and medical clients as a consultant at McKinsey & Company.

michael
Michael Davin

As Cynosure’s Chairman, President and Chief Executive Officer from 2003 to 2017, Michael Davin oversaw sales growth from $20 million to $430 million, including significant international expansion, led the company’s initial public offering and listing on the NASDAQ, and executed key acquisitions. Under his leadership, Cynosure achieved compound annual revenue growth of more than 20 percent and became one of the largest and most profitable companies in the aesthetic industry. Cynosure was sold to Hologic for $1.65 billion in March 2017.

Todd-Zavodnick
Todd Zavodnick

Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry and is currently Dermavant’s Chief Executive Officer. Prior to joining Dermavant, Mr. Zavodnick served as Chief Commercial Officer and President of Aesthetics and Therapeutics at Revance. He previously served in global leadership roles at ZELTIQ Aesthetics, prior to the company’s acquisition by Allergan, at Galderma Laboratories where he was President and General Manager of North America, and at Alcon Laboratories. He is a member of the board of directors of the Children’s Skin Disease Foundation.

logo
Krishna Gupta

Krishna Gupta is the Founder and Managing Partner of Remus Capital. A venture capital firm that focuses on building, not betting on, science- and technology-enabled companies. Mr. Gupta has been involved with Allurion since 2010, and Remus led Allurion’s $27M Series C funding. Under Mr. Gupta’s leadership, Remus has built a powerful portfolio of innovative companies and a global investor base from more than 20 countries. Mr. Gupta has extensive experience helping high-growth companies scale to become category leaders.

Ram
Dr. Ram Chuttani

Dr. Chuttani is the Chief Medical Officer and Founding Partner at Allurion Technologies Inc. Dr. Chuttani received his medical degree from Maulana Azad Medical College in New Delhi, India, in 1983.  He completed a residency at Norwalk Hospital, Yale University School of Medicine in Internal Medicine in 1987, and a fellowship in Gastroenterology at Harvard Medical School in 1990.

Dr. Chuttani is internationally recognized as a leader in digestive disease care and has pioneered several innovative endoscopic treatments.  These include confocal microscopy for early diagnosis of dysplasia/cancer in the bile ducts, radiofrequency ablation and cryotherapy treatments of Barrett’s esophagus.  Development of new methods to detect, and colonoscopically remove, both flat and very large colon polyps.  He co-invented an endoscopic treatment for GERD and co-developed a novel treatment for obesity.

Prior to joining Allurion Technologies, Dr. Chuttani was the Director of Endoscopy and Chief, Interventional Gastroenterology at Beth Israel Deaconess Medical Center and on the faculty of Harvard Medical School for 20 years. He has published over 100 original scientific articles, in addition to several reviews and book chapters.  He has lectured on, and demonstrated, novel and advanced endoscopic procedures at innumerable international conferences and workshops all over the world.

Medical Advisors
John Morton
John Morton
MD, MPH, FACS, FASMBS
logo
Bruce Schirmer
MD
Harold Solomon
Harold Solomon
MD
Peter D. Siersma
Peter D. Siersma
MD, PhD, FASGE, FACG
Richard Rothstein
Richard Rothstein
MD
George Blackburn
In memoriam
George Blackburn
MD, PhD (1936-2017)
Jordan Busch, MD
Jordan Busch
MD, FACP
Ram
Ram Chuttani
MD
Elisabeth Mathus-Vliegen
Elisabeth Mathus-Vliegen
MD, PhD
Nezam Afdhal
Nezam Afdhal
MD
Daniel Jones
Daniel Jones
MD, MS, FACS
A doctor assisting his patient about his weight loss journey

Careers

View Page